Citius Oncology Inc.CTORNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P29
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-2.59%
Q3 202517.73%
Q2 202531.82%
Q1 2025-18.15%
Q4 20244.71%
Q3 2024-38.19%
Q2 20241.26%
Q1 2024-19.33%
Q4 202383.71%
Q3 2023-638.60%
Q2 20230.88%
Q1 202360.66%
Q4 202242300.00%
Q3 202299.71%
Q2 20220.00%